# Gut Microbiome and Its Immune Modulation in Locally Advanced Rectal Cancer

> **NCT05079503** · NA · UNKNOWN · sponsor: **Korean Cancer Study Group** · enrollment: 40 (estimated)

## Conditions studied

- Locally Advanced Rectal Cancer

## Interventions

- **DRUG:** GEN-001

## Key facts

- **NCT ID:** NCT05079503
- **Lead sponsor:** Korean Cancer Study Group
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-15
- **Primary completion:** 2023-08-30
- **Final completion:** 2024-01-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05079503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05079503, "Gut Microbiome and Its Immune Modulation in Locally Advanced Rectal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05079503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*